Sub menu

 
 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

1062 result(s) found, displaying 376 to 400

  • AusPAR: Lifitegrast

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Lifitegrast

  • AusPAR: Mepolizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report Mepolizumab

  • AusPAR: Nivolumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Nivolumab

  • AusPAR: Buprenorphine

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report Buprenorphine

  • AusPAR: Pegfilgrastim

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report Pegfilgrastim

  • AusPAR: Nonacog beta pegol

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report Nonacog beta pegol

  • AusPAR: Icatibant (as acetate)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Icatibant (as acetate)

  • AusPAR: Rivaroxaban

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Rivaroxaban

  • AusPAR: Olaparib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Olaparib

  • AusPAR: Blinatumomab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Blinatumomab

  • AusPAR: Tofacitinib (as citrate)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Tofacitinib (as citrate)

  • AusPAR: Certolizumab pegol

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment for Certolizumab pegol

  • AusPAR: Tildrakizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Tildrakizumab

  • AusPAR: Galcanezumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Galcanezumab

  • AusPAR: Rituximab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment for Rituximab

  • AusPAR: Dasatinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment for Dasatinib

  • AusPAR: Osimertinib mesilate

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Osimertinib mesilate

  • AusPAR: Erenumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Erenumab

Help us improve the Therapeutic Goods Administration site